Notice2025-00349
Meeting of the Advisory Committee on Immunization Practices
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 10, 2025
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 6 (Friday, January 10, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 6 (Friday, January 10, 2025)]
[Notices]
[Pages 2002-2003]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-00349]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2025-0003]
Meeting of the Advisory Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public. Time will be available for
public comment.
DATES: The meeting will be held on February 26, 2025, from 8 a.m. to
5:10 p.m., EST, February 27, 2025, from 8 a.m. to 5 p.m., EST, and
February 28, 2025, from 8 a.m. to 11:25 a.m., EST (times subject to
change; see the ACIP website for updates: <a href="https://www.cdc.gov/acip">https://www.cdc.gov/acip</a>).
Written comments must be received between February 3-17, 2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2025-
0003, by either of the methods listed below. CDC does not accept
comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8,
Atlanta, Georgia 30329-4027. Attn: Docket No. CDC-2025-0003.
Instructions: All submissions received must include the Agency name
and docket number. All relevant comments received in conformance with
the <a href="https://www.regulations.gov">https://www.regulations.gov</a> suitability policy will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the ACIP website at <a href="https://www.cdc.gov/acip">https://www.cdc.gov/acip</a>.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management
Specialist, Advisory Committee on Immunization Practices, National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-8836; Email: <a href="/cdn-cgi/l/email-protection#6d2c2e243d2d0e090e430a021b"><span class="__cf_email__" data-cfemail="e0a1a3a9b0a0838483ce878f96">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee on Immunization Practices (ACIP) is
charged with advising the Director, Centers for Disease Control and
Prevention (CDC), on the use of immunizing agents. In addition, under
42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children program, along with schedules regarding dosing interval,
dosage, and contraindications to administration of vaccines. Further,
under applicable provisions of the Affordable Care Act and section 2713
of the Public Health Service Act, immunization recommendations of ACIP
that have been approved by the Director, CDC, and appear on CDC
immunization schedules generally must be covered by applicable health
plans.
Matters to be Considered: The agenda will include discussions on
chikungunya vaccines, COVID-19 vaccines, cytomegalovirus (CMV) vaccine,
Human papillomavirus (HPV) vaccines, influenza vaccines, meningococcal
vaccines, mpox vaccines, pneumococcal vaccines, Respiratory Syncytial
Virus (RSV) vaccines for adults, RSV vaccines for maternal and
pediatric populations, and Lyme disease. Recommendation votes are
scheduled for meningococcal vaccines, chikungunya vaccines, influenza
vaccines, and RSV vaccines for adults. Vaccines for Children (VFC)
votes are scheduled for influenza and meningococcal vaccines. Agenda
items
[[Page 2003]]
are subject to change as priorities dictate. For more information on
the meeting agenda, visit <a href="https://www.cdc.gov/acip/meetings/index.html">https://www.cdc.gov/acip/meetings/index.html</a>.
Meeting Information: The meeting will be webcast live via the World
Wide Web. For more information on ACIP, please visit the ACIP website:
<a href="https://www.cdc.gov/acip">https://www.cdc.gov/acip</a>.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near-duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments February 3-17, 2025. Written comments must be received
by February 17, 2025.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes, including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the February 26-28, 2025, ACIP meeting must
submit a request at <a href="https://www.cdc.gov/acip/meetings/index.html">https://www.cdc.gov/acip/meetings/index.html</a>
between February 3-17, 2025, and no later than 11:59 p.m., EST,
February 17, 2025 according to the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
random draw to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by February 19, 2025. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to three minutes, and each
speaker may speak only once per meeting.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2025-00349 Filed 1-8-25; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 10, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.